Food Fortification and Supplement Use—Are There Health Implications?

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 13, 2016, Pages 2149-2159

  Datta, Mridul ^a   Vitolins, Mara Z ^b  

^a PURDUE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

calcium; dietary supplements; folic acid; Food fortification

Indexed keywords

CALCIUM; FOOD ADDITIVES; NUTRIENTS; NUTRITION; ORGANIC ACIDS; VITAMINS;

DIETARY INTAKES; FOLIC ACIDS; FOOD FORTIFICATION; FORTIFIED FOODS; HEALTH IMPLICATIONS; MINERAL SUPPLEMENTS; POPULATION ESTIMATE; REGULATORY AGENCIES;

DIETARY SUPPLEMENTS;

CALCIUM INTAKE; FOLIC ACID; TRACE ELEMENT; VITAMIN D;

ADMINISTRATION AND DOSAGE; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CALCIUM INTAKE; CHILD; DIETARY SUPPLEMENT; FEMALE; FORTIFIED FOOD; HEALTH PROMOTION; HUMAN; INFANT; MALE; MIDDLE AGED; NUTRITION POLICY; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; CALCIUM, DIETARY; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HEALTH PROMOTION; HUMANS; INFANT; MALE; MICRONUTRIENTS; MIDDLE AGED; NUTRITION POLICY; UNITED STATES; VITAMIN D;

EID: 84982949072     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2013.818527     Document Type: Article

References (80)

1. American Medical Association Council on Foods and Nutrition, National Academy of Sciences (1968). Improvement of Nutritive Quality of Foods. JAMA 205:868–869.
2. J.R.Backstrand, (2002). The history and future of food fortification in the United States:a public health perspective. Nutr. Rev. 60:15–26.
3. R.L.Bailey, V.L.FulgoniIII, D.R.Keast, (2012). Examination of vitamin intakes among US adults by dietary supplement use. J. Acad. Nutr. Diet 112:657–663.
4. R.L.Bailey, V.L.Fulgoni, D.R.Keast, (2011a). Dietary supplement use is associated with higher intakes of minerals from food sources. Am. J. Clin. Nutr. 94:1376–1381.
5. R.L.Bailey, J.J.Gahche, C.V.Lentino, (2011b). Dietary supplement use in the United States, 2003–2006. J. Nutr. 141:261–266.
6. S.D.Ball, D.Kertesz, L.J.Moyer-Mileur, (2005). Dietary supplement use is prevalent among children with a chronic illness. J. Am. Diet Assoc. 105:78–84.
7. M.Bernstein, N.Munoz, (2012). Position of the academy of nutrition and dietetics:food and nutrition for older adults:promoting health and wellness. J. Acad. Nutr. Diet 112:1255–1277.
8. N.Bhoopalam, S.C.Campbell, T.Moritz, (2009). Intravenous Zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. J. Urol. 182:2257–2264.
9. D.Bishai, R.Nalubola, (2002). The history of food fortification in the united states:its relevance for current fortification efforts in developing countries. Econ. Dev. Cult. Change 51:37–53.
10. H.Blom, Y.Smulders, (2011). Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 34:75–81.
11. M.J.Bolland, A.Avenell, J.A.Baron, (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events:meta-analysis. Br. Med. J. 341.
12. M.J.Bolland, A.Grey, A.Avenell, (2011a). Calcium supplements with or without vitamin D and risk of cardiovascular events:reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. Br. Med. J. 342.
13. M.J.Bolland, A.Grey, G.D.Gamble, (2011b). Calcium and vitamin D supplements and health outcomes:a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 94:1144–1149.
14. L.M.Butler, A.S.Wong, W.-P.Koh, (2010). Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res. 70:4941–4948.
15. J.M.Chan, M.J.Stampfer, J.Ma, (2001). Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am. J. Clin. Nutr. 74:549–554.
16. B.F.Cole, J.A.Baron, R.S.Sandler, (2007). Folic acid for the prevention of colorectal adenomas. JAMA 297:2351–2359.
17. M.Datta, G.G.Schwartz, (2012). Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer:a critical review. Oncologist 17:1171–1179.
18. R.G.L.de Sévaux, A.J.Hoitsma, F.H.M.Corstens, (2002). Treatment with vitamin D and calcium reduces bone loss after renal transplantation:a randomized study. J. Am. Soc. Nephrol. 13:1608–1614.
19. B.E.Denham, (2011). Dietary supplements—regulatory issues and implications for public health. JAMA 306:428–429.
20. A.Devine, I.M.Dick, S.J.Heal, (1997). A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. Osteoporos. Int. 7:23–28.
21. J.Dwyer, R.L.Nahin, G.T.Rogers, (2013). Prevalence and predictors of children's dietary supplement use:the 2007 National Health Interview Survey. Am. J. Clin. Nutr. 97:1331–1337.
22. J.T.Dwyer, A.O.Garceau, M.Evans, (2001). Do adolescent vitamin-mineral supplement users have better nutrient intakes than nonusers? Observations from the CATCH tracking study. J. Am. Diet. Assoc. 101:1340–1346.
23. M.Ebbing, K.H.Bønaa, O.Nygård, (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302:2119–2126.
24. V.L.Fulgoni, D.R.Keast, R.L.Bailey, (2011). Foods, fortificants, and supplements:where do Americans get their nutrients? J. Nutr.
25. G.C.George, A.E.Springer, M.R.Forman, (2011). Associations among dietary supplement use and dietary and activity behaviors by sex and race/ethnicity in a representative multiethnic sample of 11th-grade students in Texas. J. Am. Diet. Assoc. 111:385–393.
26. T.M.Gibson, S.J.Weinstein, R.M.Pfeiffer, (2011). Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am. J. Clin. Nutr. 94:1053–1062.
27. J.Gilmour, C.Harrison, L.Asadi, (2011). Natural health product—drug interactions:evolving responsibilities to take complementary and alternative medicine into account. Pediatrics 128:S155–S160.
28. E.Giovannucci, Y.Liu, M.J.Stampfer, (2006). A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15:203–210.
29. S.L.Greenspan, J.B.Nelson, D.L.Trump, (2007). Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer. Ann. Intern. Med. 146:416–424.
30. S.Hirsch, H.Sanchez, C.Albala, (2009). Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur. J. Gastroenterol. Hepatol. 21:346–349.
31. M.A.Honein, L.J.Paulozzi, T.J.Mathews, (2001). Impact of folic acid fortification of the us food supply on the occurrence of neural tube defects. JAMA 285:2981–2986.
32. R.S.Israeli, S.J.Rosenberg, D.R.Saltzstein, (2007). The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. Clin. Genitourin. Cancer 5:271–277.
33. M.Kärkkäinen, M.Tuppurainen, K.Salovaara, (2010). Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65–71 years:a 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos. Int. 21:2047–2055.
34. D.Kawakita, K.Matsuo, F.Sato, (2012). Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. Ann. Oncol. 23:186–192.
35. K.J.Kemper, S.Vohra, R.Walls, (2008). The use of complementary and alternative medicine in pediatrics. Pediatrics 122:1374–1386.
36. Y.-I.Kim, (2006). Folate:a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55:1387–1389.
37. A.Z.LaCroix, J.Kotchen, G.Anderson, (2009). Calcium plus vitamin D supplementation and mortality in postmenopausal women:The Women's Health Initiative calcium–vitamin D randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci. 64A:559–567.
38. L.Langsetmo, C.Berger, N.Kreiger, (2013). Calcium and vitamin D intake and mortality:results from the Canadian Multicentre Osteoporosis Study (CaMos). J. Clin. Endocrinol. Metab.
39. K.Li, R.Kaaks, J.Linseisen, (2012). Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98:920–925.
40. A.Lim, N.Cranswick, M.South, (2011). Adverse events associated with the use of complementary and alternative medicine in children. Arch. Dis. Child. 96:297–300.
41. C.L.Martin, S.P.Murphy, R.Novotny, (2008). Contribution of dietary supplements to nutrient adequacy among children in Hawaii. J. Am. Diet. Assoc. 108:1874–1880.
42. M.E.Martínez, E.T.Jacobs, J.A.Baron, (2012). Dietary supplements and cancer prevention:balancing potential benefits against proven harms. J. Natl. Cancer Inst. 104:732–739.
43. W.Mertz, (1997). Food fortification in the United States. Nutr. Rev. 55:44–49.
44. M.D.Michaelson, D.S.Kaufman, H.Lee, (2007). Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J. Clin. Oncol. 25:1038–1042.
45. A.E.Millen, K.W.Dodd, A.F.Subar, (2004). Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States:the 1987, 1992, and 2000 National Health Interview Survey results. J. Am. Diet. Assoc. 104:942–950.
46. N.Morabito, A.Gaudio, A.Lasco, (2004). Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer. J. Bone Miner. Res. 19:1766–1770.
47. G.Moschonis, I.Katsaroli, G.P.Lyritis, (2010). The effects of a 30-month dietary intervention on bone mineral density:the Postmenopausal Health Study. Br. J. Nutr. 104:100–107.
48. S.P.Murphy, K.K.White, S.-Y.Park, (2007). Multivitamin-multimineral supplements’ effect on total nutrient intake. Am. J. Clin. Nutr. 85:280S–284S.
49. S.P.Murphy, L.R.Wilkens, K.R.Monroe, (2011). Dietary supplement use within a multiethnic population as measured by a unique inventory method. J. Am. Diet. Assoc. 111:1065–1072.
50. J.Mursu, K.Robien, L.J.Harnack, (2011). Dietary supplements and mortality rate in older women:The Iowa Women's Health Study. Arch. Intern. Med. 171:1625–1633.
51. D.H.Ndao, E.J.Ladas, Y.Bao, (2013). Use of complementary and alternative medicine among children, adolescent, and young adult cancer survivors:a survey study. J. Pediatr. Hematol. Oncol. 35:281–288.
52. G.S.Omenn, G.E.Goodman, M.D.Thornquist, (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1150–1155.
53. K.Pentti, M.T.Tuppurainen, R.Honkanen, (2009). Use of calcium supplements and the risk of coronary heart disease in 52–62-year-old women:The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 63:73–78.
54. M.F.Picciano, J.T.Dwyer, K.L.Radimer, (2007). Dietary supplement use among infants, children, and adolescents in the United States, 1999–2002. Arch. Pediatr. Adolesc. Med. 161:978–985.
55. J.Porthouse, S.Cockayne, C.King, (2005). Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330:1003–1008.
56. K.Radimer, B.Bindewald, J.Hughes, (2004). Dietary supplement use by US adults:data from the National Health and Nutrition Examination Survey, 1999–2000. Am. J. Epidemiol. 160:339–349.
57. L.Reaves, L.M.Steffen, J.T.Dwyer, (2006). Vitamin supplement intake is related to dietary intake and physical activity:the Child and Adolescent Trial for Cardiovascular Health (CATCH). J. Am. Diet. Assoc. 106:2018–2023.
58. I.R.Reid, R.W.Ames, M.C.Evans, (1995). Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women:a randomized controlled trial. Am. J. Med. 98:331–335.
59. I.H.Rosenberg, S.A.Abrams, G.R.Beecher, (2004). Dietary reference intakes:guiding principles for nutrition labeling and fortification. Nutr. Rev. 62:73–79.
60. C.W.Ryan, D.Huo, L.M.Demers, (2006). Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. J. Urol. 176:972–978.
61. F.Saad, D.M.Gleason, R.Murray, (2002). A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J. Natl. Cancer Inst. 94:1458–1468.
62. K.Salovaara, M.Tuppurainen, M.Kärkkäinen, (2010). Effect of vitamin D3 and calcium on fracture risk in 65- to 71-year-old women:a population-based 3-year randomized, controlled trial—the OSTPRE-FPS. J. Bone Miner. Res. 25:1487–1495.
63. A.Sawni-Sikand, H.Schubiner, R.L.Thomas, (2002). Use of complementary/alternative therapies among children in primary care pediatrics. Ambul. Pediatr. 2:99–103.
64. R.S.Sebastian, L.E.Cleveland, J.D.Goldman, (2007). Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J. Am. Diet. Assoc. 107:1322–1332.
65. U.Shaikh, R.S.Byrd, P.Auinger, (2009). Vitamin and mineral supplement use by children and adolescents in the 1999–2004 national health and nutrition examination survey:relationship with nutrition, food security, physical activity, and health care access. Arch. Pediatr. Adolesc. Med. 163:150–157.
66. M.R.Smith, J.Eastham, D.M.Gleason, (2003). Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J. Urol. 169:2008–2012.
67. M.R.Smith, B.Egerdie, N.H.Toriz, (2009). Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N. Engl. J. Med. 361:745–755.
68. J.Stang, M.T.Story, L.Harnack, (2000). Relationships between vitamin and mineral supplement use, dietary intake, and dietary adequacy among adolescents. J. Am. Diet. Assoc. 100:905–910.
69. P.Taxel, R.Dowsett, L.Richter, (2010). Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. BJU Int. 106:1473–1476.
70. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994). The Effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1029–1035.
71. The National Academies Press (2003) Dietary Reference Intakes:Guiding Principles for Nutrition Labeling and Fortification, Washington, DC.
72. B.B.Timbo, M.P.Ross, P.V.McCarthy, (2006). Dietary supplements in a national survey:prevalence of use and reports of adverse events. J. Am. Diet. Assoc. 106:1966–1974.
73. A.Tjonneland, J.Christensen, A.Olsen, (2005). Folate intake, alcohol and risk of breast cancer among postmenopausal women in Denmark. Eur. J. Clin. Nutr. 60:280–286.
74. U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. Available at:http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148003.htm. Accessed January 15, 2013.
75. S.Uccella, A.Mariani, A.H.Wang, (2011). Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer:a prospective cohort study. Ann. Oncol. 22:2129–2136.
76. T.K.M.Wang, M.J.Bolland, N.C.van Pelt, (2010). Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J. Bone Miner. Res. 25:2777–2785.
77. E.Warensjö, L.Byberg, H.Melhus, (2011). Dietary calcium intake and risk of fracture and osteoporosis:prospective longitudinal cohort study. BMJ 342.
78. L.-C.Weng, W.-T.Yeh, C.-H.Bai, (2008). Is ischemic stroke risk related to folate status or other nutrients correlated with folate intake? Stroke 39:3152–3158.
79. E.A.Yetley, J.I.Rader, (2004). Modeling the level of fortification and post-fortification assessments:U.S. experience. Nutr Rev 62:S50–S59.
80. S.Zhang, D.J.Hunter, S.E.Hankinson, (1999). A prospective study of folate intake and the risk of breast cancer. JAMA 281:1632–1637.